ATE263776T1 - Phosphoglycolipid und verfahren zu dessen verwendung - Google Patents

Phosphoglycolipid und verfahren zu dessen verwendung

Info

Publication number
ATE263776T1
ATE263776T1 AT99943805T AT99943805T ATE263776T1 AT E263776 T1 ATE263776 T1 AT E263776T1 AT 99943805 T AT99943805 T AT 99943805T AT 99943805 T AT99943805 T AT 99943805T AT E263776 T1 ATE263776 T1 AT E263776T1
Authority
AT
Austria
Prior art keywords
compound
deoxy
ischemia
damage due
reperfusion injury
Prior art date
Application number
AT99943805T
Other languages
English (en)
Inventor
Gary T Elliott
Patricia A Weber
Gregory C Sowell
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE263776T1 publication Critical patent/ATE263776T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT99943805T 1998-08-21 1999-08-18 Phosphoglycolipid und verfahren zu dessen verwendung ATE263776T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/138,305 US6013640A (en) 1998-08-21 1998-08-21 Phosphoglycolipid and methods for its use
PCT/US1999/019063 WO2000011010A1 (en) 1998-08-21 1999-08-18 Phosphoglycolipid and methods for its use

Publications (1)

Publication Number Publication Date
ATE263776T1 true ATE263776T1 (de) 2004-04-15

Family

ID=22481436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943805T ATE263776T1 (de) 1998-08-21 1999-08-18 Phosphoglycolipid und verfahren zu dessen verwendung

Country Status (19)

Country Link
US (2) US6013640A (de)
EP (1) EP1105401B1 (de)
JP (1) JP2002523420A (de)
KR (1) KR20010072806A (de)
CN (1) CN1324364A (de)
AT (1) ATE263776T1 (de)
AU (1) AU754186B2 (de)
BR (1) BR9913175A (de)
CA (1) CA2340649A1 (de)
CZ (1) CZ2001637A3 (de)
DE (1) DE69916289D1 (de)
HU (1) HUP0103473A3 (de)
ID (1) ID28984A (de)
IL (1) IL141496A0 (de)
NO (1) NO20010854L (de)
NZ (1) NZ510260A (de)
PL (1) PL349422A1 (de)
TR (1) TR200100636T2 (de)
WO (1) WO2000011010A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
ATE395923T1 (de) 2000-05-19 2008-06-15 Corixa Corp Prophylaktische und therapeutische behandlung von infektiösen, autoimmunen und allergischen krankheiten mit verbindungen, die auf monosacchariden basieren
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
EP1311522B1 (de) * 2000-08-04 2006-03-22 Corixa Corporation Neue immunoeffectorverbindungen
US7759803B2 (en) * 2001-07-25 2010-07-20 Rohm Co., Ltd. Semiconductor device and method of manufacturing the same
US7014991B2 (en) * 2001-11-16 2006-03-21 Infinite Vision, Llc Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
US6911434B2 (en) 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
PT1482795E (pt) * 2002-02-04 2010-02-09 Corixa Corp Novos compostos efectores imunológicos
JP2005536493A (ja) * 2002-07-08 2005-12-02 コリクサ コーポレーション 免疫エフェクターのアミノアルキルグルコサミニドホスフェートおよびジサッカライドの製造方法、ならびにその中間体
US7288640B2 (en) * 2002-07-08 2007-10-30 Corixa Corporation Processes for the production of aminoalkyl glucosaminide phosphate and disaccharide immunoeffectors, and intermediates therefor
US20050152835A1 (en) * 2003-10-31 2005-07-14 Pak Koon Y. Technetium-99M glucarate methods of use for monitoring tissues
WO2006107107A1 (ja) * 2005-04-01 2006-10-12 Fumitaka Ohsuzu リン脂質小胞体を含む心筋保護剤および虚血・再潅流時の心筋障害を予防する方法
WO2008018932A2 (en) 2006-05-01 2008-02-14 The Board Of Trustees Of The Leland Stanford Junior University Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
WO2008134830A1 (en) * 2007-03-22 2008-11-13 Fundação Butantan Method to obtain monophosphoryl lipid a from bordetella pertussis as a by-product of the cellular pertussis vaccine production
EP2268286B1 (de) * 2008-04-09 2016-04-06 The University of North Carolina At Chapel Hill Verfahren zur regulierung von aktin-zytoskelett-neuanordnung und interzellulärer zwischenraumbildung
WO2026041647A1 (en) 2024-08-19 2026-02-26 Om Pharma Sa Small molecule targeting tlr4 overexpressing tumors and associated immunosuppressive, angiogenic and fibrotic complications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5286718A (en) * 1991-12-31 1994-02-15 Ribi Immunochem Research, Inc. Method and composition for ameliorating tissue damage due to ischemia and reperfusion
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents

Also Published As

Publication number Publication date
DE69916289D1 (de) 2004-05-13
NZ510260A (en) 2002-10-25
HUP0103473A2 (hu) 2002-04-29
IL141496A0 (en) 2002-03-10
JP2002523420A (ja) 2002-07-30
NO20010854D0 (no) 2001-02-20
AU754186B2 (en) 2002-11-07
CA2340649A1 (en) 2000-03-02
US20020013291A1 (en) 2002-01-31
HUP0103473A3 (en) 2003-01-28
PL349422A1 (en) 2002-07-29
EP1105401B1 (de) 2004-04-07
BR9913175A (pt) 2001-10-09
TR200100636T2 (tr) 2002-02-21
NO20010854L (no) 2001-04-20
KR20010072806A (ko) 2001-07-31
CN1324364A (zh) 2001-11-28
CZ2001637A3 (cs) 2001-10-17
US6399590B2 (en) 2002-06-04
WO2000011010A1 (en) 2000-03-02
US6013640A (en) 2000-01-11
AU5683299A (en) 2000-03-14
ID28984A (id) 2001-07-19
EP1105401A1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
ATE263776T1 (de) Phosphoglycolipid und verfahren zu dessen verwendung
HRP20000080A2 (en) N-alkanoylphenylalanine derivatives
TR200101124T2 (tr) N-(2-aril-propiyonil)-sülfonamidler ve bunları içeren farmasötik preparasyonlar.
ES2115163T3 (es) Procedimiento para inhibir la proliferacion de celulas de musculos lisos y la restinosis.
CA2261848A1 (en) Cell adhesion inhibitors
WO2001022953A3 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
CA2296036A1 (en) Dolastatin 15 derivatives
BR9307235A (pt) M-todos para combater pneumonia de pneumocystis carinni e compostos Úteis para os mesmos
UA41355C2 (uk) Засіб для лікування нейро-сніду
NO934721L (no) Hemmere av HIV-protease som er nyttige for behandling av AIDS
FI94354C (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
BR9912684A (pt) Composto de fórmula (i), composição farmacêutica compreendendo o composto, método, processo e seu uso
ATE27269T1 (de) Strahlenschutzmittel mit aminothioalkyl-struktur und verfahren zu ihrer herstellung.
RU97104786A (ru) Раствор для защиты роговицы от повреждений "визиотон i"
WO1992017065A3 (en) Method of inhibiting fibrosis
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
CA2362833A1 (en) Phenylalaninol derivatives
AU1951499A (en) Use of mek1 inhibitors as protective agents against damage due to ischemia
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
RU93019277A (ru) Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
FI970165A7 (fi) (S)-atenosyyli-L-metioniinin (SAMe) ja sen fysiologisesti hyväksyttävi en suolojen käyttö tilapäisen fokaalisen iskemian aiheuttamien reperfu usiovammojen hoitamiseksi
JPS5513285A (en) Imidazoline compound and medical composition
DE3569458D1 (en) Agent for the protection of and for combating damage caused to the vegetation
ZA993528B (en) A compound for use in treating glaucoma and ischemic retinopathy.
ITTO920022A0 (it) Procedimento per la purificazione di n-alchil urea di grado tecnico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties